These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 24771265)
21. MicroRNA-107 induces cell cycle arrests by directly targeting cyclin E1 in ovarian cancer. Tang Z; Fang Y; Du R Biochem Biophys Res Commun; 2019 Apr; 512(2):331-337. PubMed ID: 30885433 [TBL] [Abstract][Full Text] [Related]
22. Role of EZH2 in the growth of prostate cancer stem cells isolated from LNCaP cells. Li K; Liu C; Zhou B; Bi L; Huang H; Lin T; Xu K Int J Mol Sci; 2013 Jun; 14(6):11981-93. PubMed ID: 23739676 [TBL] [Abstract][Full Text] [Related]
23. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin. Li CH; To KF; Tong JH; Xiao Z; Xia T; Lai PB; Chow SC; Zhu YX; Chan SL; Marquez VE; Chen Y Gastroenterology; 2013 May; 144(5):1086-1097.e9. PubMed ID: 23395645 [TBL] [Abstract][Full Text] [Related]
24. EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients. Rao ZY; Cai MY; Yang GF; He LR; Mai SJ; Hua WF; Liao YJ; Deng HX; Chen YC; Guan XY; Zeng YX; Kung HF; Xie D Carcinogenesis; 2010 Sep; 31(9):1576-83. PubMed ID: 20668008 [TBL] [Abstract][Full Text] [Related]
25. [miR-503-5p inhibits the proliferation of T24 and EJ bladder cancer cells by interfering with the Rb/E2F signaling pathway]. Li X; Han X; Yang J; Sun J; Wei P Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Oct; 33(10):1360-1364. PubMed ID: 29169421 [TBL] [Abstract][Full Text] [Related]
26. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma. Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240 [TBL] [Abstract][Full Text] [Related]
27. microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer. Chen DL; Zhang DS; Lu YX; Chen LZ; Zeng ZL; He MM; Wang FH; Li YH; Zhang HZ; Pelicano H; Zhang W; Xu RH Oncotarget; 2015 May; 6(13):10868-79. PubMed ID: 25869101 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA-144 suppresses tumorigenesis and tumor progression of astrocytoma by targeting EZH2. Lin L; Zheng Y; Tu Y; Wang Z; Liu H; Lu X; Xu L; Yuan J Hum Pathol; 2015 Jul; 46(7):971-80. PubMed ID: 25907866 [TBL] [Abstract][Full Text] [Related]
29. MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma. Xia H; Ooi LL; Hui KM PLoS One; 2012; 7(9):e44206. PubMed ID: 22962603 [TBL] [Abstract][Full Text] [Related]
30. NF-YA underlies EZH2 upregulation and is essential for proliferation of human epithelial ovarian cancer cells. Garipov A; Li H; Bitler BG; Thapa RJ; Balachandran S; Zhang R Mol Cancer Res; 2013 Apr; 11(4):360-9. PubMed ID: 23360797 [TBL] [Abstract][Full Text] [Related]
31. EZH2-miR-30d-KPNB1 pathway regulates malignant peripheral nerve sheath tumour cell survival and tumourigenesis. Zhang P; Garnett J; Creighton CJ; Al Sannaa GA; Igram DR; Lazar A; Liu X; Liu C; Pollock RE J Pathol; 2014 Feb; 232(3):308-18. PubMed ID: 24132643 [TBL] [Abstract][Full Text] [Related]
32. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest. Mann DJ; Jones NC Curr Biol; 1996 Apr; 6(4):474-83. PubMed ID: 8723352 [TBL] [Abstract][Full Text] [Related]
33. Deficiency of G1 regulators P53, P21Cip1 and/or pRb decreases hepatocyte sensitivity to TGFbeta cell cycle arrest. Sheahan S; Bellamy CO; Dunbar DR; Harrison DJ; Prost S BMC Cancer; 2007 Nov; 7():215. PubMed ID: 18021445 [TBL] [Abstract][Full Text] [Related]
34. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression. Keenan SM; Lents NH; Baldassare JJ J Biol Chem; 2004 Feb; 279(7):5387-96. PubMed ID: 14645251 [TBL] [Abstract][Full Text] [Related]
35. Antitumor effects of pharmacological EZH2 inhibition on malignant peripheral nerve sheath tumor through the miR-30a and KPNB1 pathway. Zhang P; Yang X; Ma X; Ingram DR; Lazar AJ; Torres KE; Pollock RE Mol Cancer; 2015 Mar; 14():55. PubMed ID: 25890085 [TBL] [Abstract][Full Text] [Related]
36. Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex. Le Cam L; Polanowska J; Fabbrizio E; Olivier M; Philips A; Ng Eaton E; Classon M; Geng Y; Sardet C EMBO J; 1999 Apr; 18(7):1878-90. PubMed ID: 10202151 [TBL] [Abstract][Full Text] [Related]
37. Cyclin E-induced S phase without activation of the pRb/E2F pathway. Lukas J; Herzinger T; Hansen K; Moroni MC; Resnitzky D; Helin K; Reed SI; Bartek J Genes Dev; 1997 Jun; 11(11):1479-92. PubMed ID: 9192874 [TBL] [Abstract][Full Text] [Related]
39. The extreme COOH terminus of the retinoblastoma tumor suppressor protein pRb is required for phosphorylation on Thr-373 and activation of E2F. Gorges LL; Lents NH; Baldassare JJ Am J Physiol Cell Physiol; 2008 Nov; 295(5):C1151-60. PubMed ID: 18768921 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma. Huang SD; Yuan Y; Zhuang CW; Li BL; Gong DJ; Wang SG; Zeng ZY; Cheng HZ Mol Cancer; 2012 Aug; 11():51. PubMed ID: 22867052 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]